Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medco/Washington Rx Plan Offers Mail Discounts Up To 49%, 30% At Retail

Executive Summary

Merck-Medco will provide seniors in Washington state with discounts of up to 49% on mail-order prescription drug purchases through a new program initiated in conjunction with the governor's office.

You may also be interested in...



Florida Rx Discount Program For Elderly To Receive HCFA Review

Florida will file a Medicaid state plan amendment for its program that offers Medicaid prescription drug prices to Medicare beneficiaries.

Florida Rx Discount Program For Elderly To Receive HCFA Review

Florida will file a Medicaid state plan amendment for its program that offers Medicaid prescription drug prices to Medicare beneficiaries.

Vermont Rx Discount Program Expects To Enroll 30% Of Eligibles In 2001

Vermont expects to enroll approximately 30% of the 68,900 individuals eligible for prescription drug coverage through its new Pharmacy Discount Program by the end of 2001, the Office of Vermont Health Access said.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel